Project using stem cell-derived tissues to rapidly test drugs already approved for use in humans for activity against COVID-19.
- Funded by Australian Government (Australian Research Council)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AKnown Financial Commitments (USD)
$1,913,724.87Funder
Australian Government (Australian Research Council)Research Location
AustraliaLead Research Institution
Peter Doherty Institute for Infection and Immunity; Queensland Institute of Medical Research BerghoferResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Prophylactic use of treatmentsSpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
Project using stem cell-derived tissues to rapidly test drugs already approved for use in humans for activity against COVID-19.